BeStock  
Stocks › Biotechnology › AUPH

Aurinia Pharmaceuticals AUPH

US equityMarket cap rank #2690Biotechnology
$14.70 −$0.19 (-1.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.64 -0.41%
Open$14.69
Prev close$14.89
Day range$14.63 – $14.97
Volume1.34M
Market cap$1.97B
P/E (TTM)6.4
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings6.9x
CheapRich

Above its usual level · 67th percentile, 5-year average 2.8x

#314 of 2993 stocks by PE (1 = cheapest)

Price / book3.2x
CheapRich

Around its usual level · 46th percentile, 5-year average 3.6x

#3852 of 5330 stocks by PB (1 = cheapest)

Price / sales6.6x
CheapRich

Below its usual level · 39th percentile, 5-year average 10.5x

#4199 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-84x20x125x230xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$15.73
Price vs. fair value-6.6%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.21 – 3.59 46% (cheaper than usual) #3852 of 5330 (1 = cheapest)
PE 6.90 19.92 2.84 67% (pricier than usual) #314 of 2993 (1 = cheapest)
PS 6.55 5.74 10.52 39% (cheaper than usual) #4199 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on AUPH.

Sign in to join the discussion.

Scroll to Top